-
Groups Tour National Lab as Part of Conference Programs
The UTMB campus has been busy this spring with several conferences and meetings that have attracted attendees from around the world. This group of visitors were attending the FDA/UTMB training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories and came to the GNL for a tour. Tours offer GNL personnel the chance to share information about the research taking place in the building and the complex operations.
-
-
General Secretariat of Brazil's Ministry of Defense Visits GNL
Personnel from the GNL hosted representatives from Brazil's Ministry of Defense to share best practices in laboratory design, operation and safety. Brazil is in the planning phase for new high containment labs to manage emerging infectious disease research.
-
Infectious Science Podcast: All About Avian Flu
In this episode, listeners will come away with a wealth of knowledge about bird flu strains, how they spread, the risk to migratory bird populations, commercial flocks, backyard chickens and mammals.
-
Research uncovers possible monoclonal antibody treatment for Lassa fever
In a paper published in the journal Proceedings of the National Academy of Sciences, UTMB’s scientists document how a new drug from Zalgen Labs successfully cured cynomolgus monkeys infected with Lassa virus.
-
UTMB Welcomes Dr. Jochen Reiser as new President
A new president has taken over at the University of Texas Medical Branch. This interview appeared in the Galveston County Daily News.
-
Focusing on Treatments for Neglected Diseases
The first clinical trial testing two drugs to treat Crimean Congo Hemorrhagic Fever is underway in Turkey, and UTMB’s Dr. Gary Kobinger is one of the forces behind this successful project.
-
Students from Taiwan Visit UTMB
Six undergraduate students from Asia University in Taiwan who are studying healthcare administration received an introduction to healthcare systems in America during a day at UTMB on Monday, July 17.
-
-
Sharing Expertise with International Visitors
The Galveston National Lab hosted an impressive group of visitors on Friday, June 2.
-
Team Wins New Grant for Vaccine Development
Dr. Tom Geisbert and Dr. Robert Cross are co-PIs on a new project agreement awarded by the US Department of Defense and BARDA for vaccine development targeting pathogens of concern to U.S. Military.
-
-
-
-
-
BSL4 scientists develop Nipah virus vaccine
A new study published in Proceedings of the National Academy of Sciences details the development of a new vaccine to combat Nipah virus.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
From STAT: Fast Track for Vaccines
In this article by STAT's Andrew Joseph, the author details the challenges of creating a new vaccine for COVID-19, explains how the process is being fast-tracked, and discusses the gambles being taken on manufacturing in advance of approvals in hopes of positive clinical trial results. UTMB's Dr. Jim Le Duc, Director of the Galveston National Lab, is featured as one of the experts in the story. Click on the photo for the full story.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-